Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VitaDAO is a decentralized longevity-focused biotech collective that funds, incubates, and helps commercialize early-stage research aimed at extending human healthspan and lifespan. The organization combines community governance, on-chain funding mechanisms, and AI-assisted research workflows to source and advance projects across aging biology, neurodegeneration, autophagy, and age-related disease. Rather than operating as a conventional single-asset drug developer, VitaDAO supports a portfolio of translational programs and has also helped launch spinout companies in longevity biotech. Its activities span target discovery, drug discovery, preclinical development, and selected clinical-stage collaborations within the broader aging and geroscience ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vita.